194 related articles for article (PubMed ID: 12568485)
21. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.
Bridevaux PO; Gerbase MW; Probst-Hensch NM; Schindler C; Gaspoz JM; Rochat T
Thorax; 2008 Sep; 63(9):768-74. PubMed ID: 18505800
[TBL] [Abstract][Full Text] [Related]
22. Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease.
Matheson MC; Benke G; Raven J; Sim MR; Kromhout H; Vermeulen R; Johns DP; Walters EH; Abramson MJ
Thorax; 2005 Aug; 60(8):645-51. PubMed ID: 16061705
[TBL] [Abstract][Full Text] [Related]
23. Smoking: relationship to chronic bronchitis, chronic obstructive pulmonary disease and mortality.
Pelkonen M
Curr Opin Pulm Med; 2008 Mar; 14(2):105-9. PubMed ID: 18303418
[TBL] [Abstract][Full Text] [Related]
24. Chronic mucus hypersecretion: prevalence and risk factors in younger individuals.
Harmsen L; Thomsen SF; Ingebrigtsen T; Steffensen IE; Skadhauge LR; Kyvik KO; Backer V
Int J Tuberc Lung Dis; 2010 Aug; 14(8):1052-8. PubMed ID: 20626952
[TBL] [Abstract][Full Text] [Related]
25. Is respiratory mucus hypersecretion really an innocent disorder? A 22-year mortality survey of 1,061 working men.
Annesi I; Kauffmann F
Am Rev Respir Dis; 1986 Oct; 134(4):688-93. PubMed ID: 3767125
[TBL] [Abstract][Full Text] [Related]
26. Airway mucus hypersecretion in asthma: an undervalued pathology?
Rogers DF
Curr Opin Pharmacol; 2004 Jun; 4(3):241-50. PubMed ID: 15140415
[TBL] [Abstract][Full Text] [Related]
27. Pathogenesis of COPD.
Spurzem JR; Rennard SI
Semin Respir Crit Care Med; 2005 Apr; 26(2):142-53. PubMed ID: 16088433
[TBL] [Abstract][Full Text] [Related]
28. Effect of living close to a main road on asthma, allergy, lung function and chronic obstructive pulmonary disease.
Pujades-Rodríguez M; Lewis S; McKeever T; Britton J; Venn A
Occup Environ Med; 2009 Oct; 66(10):679-84. PubMed ID: 19770354
[TBL] [Abstract][Full Text] [Related]
29. Health outcomes associated with lung function decline and respiratory symptoms and disease in a community cohort.
Baughman P; Marott JL; Lange P; Andrew M; Hnizdo E
COPD; 2011 Apr; 8(2):103-13. PubMed ID: 21495838
[TBL] [Abstract][Full Text] [Related]
30. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
31. Non-allergic models of mucous cell metaplasia and mucus hypersecretion in rat nasal and pulmonary airways.
Harkema JR; Wagner JG
Novartis Found Symp; 2002; 248():181-97; discussion 197-200, 277-82. PubMed ID: 12568495
[TBL] [Abstract][Full Text] [Related]
32. Physiology of airway mucus secretion and pathophysiology of hypersecretion.
Rogers DF
Respir Care; 2007 Sep; 52(9):1134-46; discussion 1146-9. PubMed ID: 17716382
[TBL] [Abstract][Full Text] [Related]
33. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes.
Lange P; Nyboe J; Appleyard M; Jensen G; Schnohr P
Thorax; 1990 Aug; 45(8):579-85. PubMed ID: 2402719
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease.
Albers M; Schermer T; Heijdra Y; Molema J; Akkermans R; van Weel C
Thorax; 2008 Mar; 63(3):201-7. PubMed ID: 17905823
[TBL] [Abstract][Full Text] [Related]
35. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD).
Hallin R; Gudmundsson G; Suppli Ulrik C; Nieminen MM; Gislason T; Lindberg E; Brøndum E; Aine T; Bakke P; Janson C
Respir Med; 2007 Sep; 101(9):1954-60. PubMed ID: 17532198
[TBL] [Abstract][Full Text] [Related]
36. [Fire fighters as a high-risk group of pathological changes in the respiratory tract].
Witt M
Przegl Lek; 2005; 62(10):986-8. PubMed ID: 16521934
[TBL] [Abstract][Full Text] [Related]
37. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
38. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.
Watson L; Vonk JM; Löfdahl CG; Pride NB; Pauwels RA; Laitinen LA; Schouten JP; Postma DS;
Respir Med; 2006 Apr; 100(4):746-53. PubMed ID: 16199147
[TBL] [Abstract][Full Text] [Related]
39. [Measurement of lung function in patients admitted to hospital with acute exacerbation of chronic obstructive pulmonary disease or asthma].
Lange P; Rasmussen L; Said NM; Ravnholt MM
Ugeskr Laeger; 2005 Nov; 167(48):4563-6. PubMed ID: 16324438
[TBL] [Abstract][Full Text] [Related]
40. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
